http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102838592-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e2b7361978d9ff4829de745aac79548
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
filingDate 2012-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02eddfc190d4c5f17c7f6a675432f7a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e164cd03e5228eb4d5dcea4150b9a1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bb0c1a8db0260f0e21cf34cbbfe1a44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6347a5044cb480c4ecd27e0721fb65d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f130db1fb4511b112c4f6cba390b8314
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ea16328665a4db8f485fe6afff7f85c3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72a0bbf4f6faae9b36bc30591d865eb2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2d2efaea29b34b2acb5bfa0fa960d42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e2cc3f7bbb052ef00a3f10a950d173f5
publicationDate 2012-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102838592-A
titleOfInvention 2,4-diaryl thiazole derivative, and pharmaceutical composition, preparation method and application thereof
abstract The invention belongs to the field of pharmaceutical chemicals, relates to a 2,4-diaryl thiazole derivative, and a pharmaceutical composition, a preparation method and application of the 2,4-diaryl thiazole derivative, and in particular relates to a compound shown in the formula I or a pharmaceutically acceptable salt of the compound, wherein R1 is of a structure shown in the formula II or III, R2, R3, R4, R5, R6, R7, R8 and R9 are independently selected from hydrogen, hydroxyl, C1-C6 straight-chain or branched-chain alkyl, C1-C6 straight-chain or branched-chain alkoxy, substituted or unsubstituted benzyloxy, and halogen atoms (F, Cl and Br); when single bond is represented, X is selected from NH, S, O, CH2, SCH=CH, CH=CH, N=CH and CH=N; when double bond is represented, X is selected from N and CH; Y is selected from NH, S, O, CH2, CH=CH, N=CH and CH=N; Z is selected from NH, S, O, CH2, CH=CH, N=CH and CH=N. The pharmaceutical composition disclosed by the invention can effectively inhibit tumor cells and has prospect in antineoplastic drugs.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103739606-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103739606-A
priorityDate 2011-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466271439
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466271441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466541468

Total number of triples: 27.